Document Type

Patent

Publication Date

October 2007

Patent Number

7276581

Abstract

The present invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. Methods for isolating, expressing and characterizing recombinant Src mutant polypeptide are also provided. The invention further relates to methods for utilizing such oligonucleotides, polypeptides, agonists and antagonists for applications, which relate to research, diagnostics, and clinical arts. More specifically, this invention provides methods of diagnosing, treating, immunizing, and creating transgenic animals based on use of such mutant Src.

Application Number

10/887,588

Assignees

University of South Florida

Filing Date

07/09/2004

Primary/U.S. Class

530/350

Share

COinS